Chris Rafael

Chris Rafael is a seasoned professional in regulatory publishing and operations, currently serving as Senior Director at BridgeBio since July 2020, after progressing through multiple roles including Director and Associate Director. Prior experience includes positions at La Jolla Pharmaceutical Company, IGNYTA, Inc., Ardea Biosciences, Cadence Pharmaceuticals, and Pfizer, where responsibilities encompassed managing regulatory operations and submissions. Chris Rafael began a career in regulatory operations at Agouron Pharmaceuticals and has developed expertise through various roles over nearly two decades, supported by a Bachelor of Science in Health Science with a concentration in Health Administration from California State University, Northridge.